|
Mycoplasma infections and different human carcinomas. |
90.00% |
|
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. |
90.00% |
|
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. |
90.00% |
|
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta |
90.00% |
|
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug |
90.00% |
|
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. |
90.00% |
|
Albumin Concentration Controls Cancer |
90.00% |
|
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure |
90.00% |
|
Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. |
90.00% |
|
71 year old woman, Pancraetic cancer with liver and lung metastasis. |
90.00% |
|
Efficacy of homeopathic therapy in cancer treatment |
90.00% |
|
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. |
90.00% |
|
Opioid growth factor and the treatment of human pancreatic cancer: a review. |
90.00% |
|
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. |
90.00% |
|
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy |
90.00% |
|
Hyperthermia adds to chemotherapy. |
90.00% |
|
Metabolic modulation of glioblastoma with dichloroacetate. |
90.00% |
|
Clinical Investigations on Ukrain |
90.00% |
|
Open Source Cancer Resaearch - A video |
90.00% |
|
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. |
90.00% |
|
Role of infectious agents in the emergence of malignant tumors |
90.00% |
|
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp |
90.00% |
|
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. |
90.00% |
|
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: |
90.00% |
|
Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic soli |
90.00% |
|
Pre-Clinical Investigations on Ukrain |
90.00% |
|
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca |
90.00% |
|
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. |
90.00% |
|
Adaptive therapy. |
90.00% |
|
71 year old woman. Breast cancer with bone metastasis |
90.00% |
|
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti |
90.00% |
|
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. |
90.00% |
|
Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in ........ |
90.00% |
|
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. |
90.00% |
|
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and |
90.00% |
|
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. |
90.00% |
|
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... |
90.00% |
|
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. |
90.00% |
|
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esoph |
90.00% |
|
Debate in Lancet about setting up a phase II trial on Ukrain in England |
90.00% |
|
Vitamin D for cancer prevention: global perspective. |
90.00% |
|
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell |
90.00% |
|
Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy |
90.00% |
|
Artesunate in the treatment of metastatic uveal melanoma--first experiences. |
90.00% |
|
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). |
90.00% |
|
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. |
90.00% |
|
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. |
90.00% |
|
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a |
90.00% |
|
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. |
90.00% |
|
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent |
90.00% |
|
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. |
90.00% |
|
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. |
90.00% |
|
Tumor therapy with Amanita phalloides (death cap): stabilization of B-cell chronic lymphatic leukemia. |
90.00% |
|
42 year old man. Kidney cancer |
90.00% |
|
Artemisinin derivates in the treatment of Cancer |
90.00% |
|
Dichloroacetic acid |
90.00% |
|
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor |
90.00% |
|
Why We Get Sick And How to Get Well |
90.00% |
|
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. |
90.00% |
|
Is it time to test metformin in breast cancer clinical trials? |
90.00% |
|
The present state of antineoplaston research (1) |
90.00% |
|
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice |
90.00% |
|
Effects of CANELIM capsule drug-contained serum on viscoelasticity |
90.00% |
|
The use of mushroom glucans and proteoglycans in cancer treatment. |
90.00% |
|
Medicinal plants and cancer chemoprevention. |
90.00% |
|
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced |
90.00% |
|
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, |
90.00% |
|
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications |
90.00% |
|
Why are tumour blood vessels abnormal and why is it important to know? |
90.00% |
|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. |
90.00% |
|
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. |
90.00% |
|
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ |
90.00% |
|
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. |
90.00% |
|
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. |
90.00% |
|
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. |
90.00% |
|
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors |
90.00% |
|
Chemotherapy of advanced epithelial cancer--a critical review |
90.00% |
|
MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. |
90.00% |
|
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. |
90.00% |
|
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. |
90.00% |
|
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. |
90.00% |
|
Mistletoe therapy in oncology |
90.00% |
|
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. |
90.00% |
|
Metronomic chemotherapy: changing the paradigm that more is better. |
90.00% |
|
Psorinum, the anti cancer miracle from India. |
91.47% |
|
Low-dose naltrexone for disease prevention and quality of life. |
95.00% |
|
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... |
95.00% |
|
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. |
95.00% |
|
Ukrain (NSC-631570) in the treatment of pancreas cancer. |
95.00% |
|
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. |
95.00% |
|
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. |
95.00% |
|
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? |
97.50% |
|
DCA |
97.50% |
|
Why is not Ukrain approved yet in Austria/EU? |
98.57% |
|
Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. |
100.00% |
|
IS THERE A COVID VACCINE / CANCER CONNECTION? |
100.00% |
|
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma. |
100.00% |
|
Psychodynamic pain management for cancer patients |
100.00% |
|
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s |
100.00% |
|
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer. |
100.00% |
